CARRIE MONTGOMERY: Open Payments
NPI 1871256628 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 19 payments from 8 companies in 2025. Trend: 2023 $892 · 2024 $492 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Novo Nordisk Inc | 3 | $61 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Exact Sciences Corporation | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, Ozempic, Rybelsus, GARDASIL 9, SHINGRIX, FARXIGA, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
